Edition:
United Kingdom

Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

20.00USD
25 Jun 2019
Change (% chg)

$-0.43 (-2.10%)
Prev Close
$20.43
Open
$20.65
Day's High
$20.76
Day's Low
$19.95
Volume
173,663
Avg. Vol
181,277
52-wk High
$43.85
52-wk Low
$19.95

About

Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for patients with severe and life-threatening diseases. The Company operates through the business of developing and commercializing therapeutics segment. The Company is focused on developing allogeneic or... (more)

Overall

Beta: --
Market Cap(Mil.): $495.06
Shares Outstanding(Mil.): 30.56
Dividend: --
Yield (%): --

Financials

  ATRA.OQ Industry Sector
P/E (TTM): -- 69.29 32.55
EPS (TTM): -3.33 -- --
ROI: -36.94 8.90 13.82
ROE: -37.81 10.04 15.24

BRIEF-Atara Biotherapeutics Appoints Pascal Touchon As Chief Executive Officer

* ATARA BIOTHERAPEUTICS APPOINTS PASCAL TOUCHON PRESIDENT, CHIEF EXECUTIVE OFFICER AND MEMBER OF THE BOARD OF DIRECTORS

28 May 2019

Earnings vs. Estimates